Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Provision of Point of Care CD4 Technology and Early Knowledge of CD4 Levels Affect Early Initiation and Retention on Anti-retroviral Treatment (ART) in HIV Positive Pregnant Women in the Context of Option B+ for PMTCT?

NCT02070900 is registered in ClinicalTrials.gov with WHO, Department of Maternal, Newborn, Child and Adolescent Health as lead sponsor.

NCT NCT02070900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02070900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Provision of Point of Care CD4 Technology and Early Knowledge of CD4 Levels Affect Early Initiation and Retention on Anti-retroviral Treatment (ART) in HIV Positive Pregnant Women in the Context of Option B+ for PMTCT?
Lead sponsor
WHO, Department of Maternal, Newborn, Child and Adolescent Health
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2014
Completion date
July 31, 2016
Enrollment
704 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

hiv/aids